Friends Research Institute and Department of Criminal Justice, Stevenson University, Baltimore, MD 21201, USA.
Behav Sci Law. 2011 Nov-Dec;29(6):829-45. doi: 10.1002/bsl.1015.
Creating, implementing and evaluating substance abuse interventions, especially medication-assisted treatments, for prisoners, parolees, and probationers with histories of heroin addiction is an especially challenging endeavor because of the difficulty in coordinating and achieving cooperation among diverse criminal justice, substance abuse treatment, research, and social service agencies, each with its own priorities and agenda. In addition, there are special rules that must be followed when conducting research with criminal justice-involved populations, particularly prisoners. The following case studies will explore the authors' experience of over 10 years conducting pharmacotherapy research using methadone, buprenorphine, and naltrexone with criminal justice populations. The major obstacles and how they were overcome are presented. Finally, recommendations are provided with regard to implementing and conducting research with criminal justice populations.
为有海洛因成瘾史的囚犯、假释犯和缓刑犯创建、实施和评估药物滥用干预措施，特别是药物辅助治疗，是一项极具挑战性的工作，因为协调和实现不同的刑事司法、药物滥用治疗、研究和社会服务机构之间的合作具有难度，每个机构都有自己的优先事项和议程。此外，在对涉及刑事司法的人群，特别是囚犯进行研究时，必须遵循特殊的规则。以下案例研究将探讨作者在过去 10 多年中使用美沙酮、丁丙诺啡和纳曲酮对刑事司法人群进行药物治疗研究的经验。介绍了主要障碍及其克服方法。最后，就如何与刑事司法人群一起实施和开展研究提供了建议。
